 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$2.71 |
$2.74 |
$2.51 |
$2.64 |
2.31M | | 04/22/2024 |
$2.60 |
$2.71 |
$2.58 |
$2.59 |
2.09M | | 04/23/2024 |
$2.70 |
$3.15 |
$2.70 |
$2.80 |
6.56M | | 04/24/2024 |
$2.82 |
$2.86 |
$2.64 |
$2.65 |
2.17M | | 04/25/2024 |
$2.66 |
$2.66 |
$2.46 |
$2.55 |
2.20M |
|
|
| Heron Therapeutics is a commercial-stage biotechnology company focused on developing treatments for acute care and oncology patients. Co.'s oncology care product portfolio includes SUSTOL, which is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide combination chemotherapy regimens. Co.'s acute care product portfolio includes: ZYNRELEF, which is indicated in adults for soft tissue or periarticular instillation; and APONVIE (HTX-019), which is indicated for the prevention of postoperative nausea and vomiting in adults. | |
|
Heron Therapeutics (HRTX) has the following price history information. Looking back at HRTX historical stock prices for the last five trading days, on April 19, 2024, HRTX opened at $2.71, traded as high as $2.74 and as low as $2.51, and closed at $2.64. Trading volume was a total of 2.31M shares. On April 22, 2024, HRTX opened at $2.60, traded as high as $2.71 and as low as $2.58, and closed at $2.59. Trading volume was a total of 2.09M shares. On April 23, 2024, HRTX opened at $2.70, traded as high as $3.15 and as low as $2.70, and closed at $2.80. Trading volume was a total of 6.56M shares. On April 24, 2024, HRTX opened at $2.82, traded as high as $2.86 and as low as $2.64, and closed at $2.65. Trading volume was a total of 2.17M shares. On April 25, 2024, HRTX opened at $2.66, traded as high as $2.66 and as low as $2.46, and closed at $2.55. Trading volume was a total of 2.20M shares.
HRTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Heron Therapeutics shares, starting with a $10,000 purchase of HRTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/29/2014 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$11.91 |
|
| End price/share: |
$2.55 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-78.59% |
|
| Average Annual Total Return: |
-14.29% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,140.42 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/19/2024 | $2.64 | | 04/22/2024 | $2.59 | | 04/23/2024 | $2.80 | | 04/24/2024 | $2.65 | | 04/25/2024 | $2.55 |
|
|
Free HRTX Email Alerts:
